93 related articles for article (PubMed ID: 32360)
1. Long-lasting inhibition of angiotensin response in rats by depot administration of octanoyl-[Leu8]-angiotensin II.
Abdulkader RC; Silva HB; Marcondes M; Vasconcelos EA; Paiva AC
J Pharm Pharmacol; 1979 Jan; 31(1):20-2. PubMed ID: 32360
[TBL] [Abstract][Full Text] [Related]
2. Selective pharmacological effects of triprolyl and pentasarcosyl angiotensin II.
Mikami H; Ogihara T; Katahira K; Imai N; Kumahara Y; Bumpus FM; Khosla MC
J Cardiovasc Pharmacol; 1987 Feb; 9(2):242-5. PubMed ID: 2436006
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of octanoyl[8-leucyl]angiotensin II, a lipophilic angiotensin antagonist.
Paiva AC; Nouailhetas VL; Paiva TB
J Med Chem; 1977 Jul; 20(7):898-901. PubMed ID: 874965
[TBL] [Abstract][Full Text] [Related]
4. Effect of inhibition of central angiotensin pressor mechanisms on blood pressure in spontaneously hypertensive rats.
Bruner CA; Kuslikis BI; Fink GD
J Cardiovasc Pharmacol; 1987 Mar; 9(3):298-304. PubMed ID: 2437396
[TBL] [Abstract][Full Text] [Related]
5. Effects of intracerebroventricular infusion of angiotensin II and related peptides on water and sodium ingestion and excretion.
Gonçalves JR; Camargo LA; Menani JV; Saad WA; Saad WA; Renzi A; De Luca Júnior LA
Braz J Med Biol Res; 1988; 21(3):615-9. PubMed ID: 3228647
[TBL] [Abstract][Full Text] [Related]
6. Time course of losartan blockade of angiotensin II hypertension versus blockade of angiotensin II fast pressor effects.
Gorbea-Oppliger VJ; Melaragno MG; Potter GS; Petit RL; Fink GD
J Pharmacol Exp Ther; 1994 Nov; 271(2):804-10. PubMed ID: 7965799
[TBL] [Abstract][Full Text] [Related]
7. (Des-Asp1) angiotensin I: a study of its pressor and steroidogenic activities in conscious rats.
Campbell WB; Schmitz JM; Itskovitz HD
Endocrinology; 1977 Jan; 100(1):46-51. PubMed ID: 187407
[TBL] [Abstract][Full Text] [Related]
8. Long-acting angiotensin II inhibitors containing hexafluorovaline in position 8.
Hsieh KH; Needleman P; Marshall GR
J Med Chem; 1987 Jun; 30(6):1097-100. PubMed ID: 3585907
[TBL] [Abstract][Full Text] [Related]
9. Effect of angiotensin II and an angiotensin II inhibitor on renin secretion in the dog.
McDonald KM; Taher S; Aisenbrey G; De Torrente A; Schrier RW
Am J Physiol; 1975 May; 228(5):1562-7. PubMed ID: 1130560
[TBL] [Abstract][Full Text] [Related]
10. Cerebroventricular infusion of angiotensin antagonist does not influence hypertensive response to blood-borne angiotensin II.
Bruner CA; Fink GD
Brain Res; 1985 Dec; 360(1-2):15-23. PubMed ID: 4075167
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular actions of angiotensin in the fowl (Gallus domesticus). II. Angiotensin analog agonists and antagonists.
Moore AF; Strong JH; Buckley JP
Res Commun Chem Pathol Pharmacol; 1981 Jun; 32(3):447-57. PubMed ID: 6267670
[TBL] [Abstract][Full Text] [Related]
12. Interactions between angiotensin II, sympathetic nerve-mediated pressor response and cyclo-oxygenase products in the pithed rat.
Grant TL; McGrath JC
Br J Pharmacol; 1988 Dec; 95(4):1220-8. PubMed ID: 3146400
[TBL] [Abstract][Full Text] [Related]
13. The effect of analogues of angiotensin II on drinking and cardiovascular responses to central angiotensin II in the rat.
Camargo LA; De Luca LA; Menani JV; Renzi A; Saad WA; Saad WA; Silveira JE
J Physiol; 1991 Nov; 443():513-8. PubMed ID: 1822536
[TBL] [Abstract][Full Text] [Related]
14. The effect of 1-sarcosine, 8-leucyl angiotensin II on the pressor effect of infused angiotensin II.
O'Connor GJ; Baranowski RL; Kurtzman NA
Arch Int Pharmacodyn Ther; 1974 May; 209(1):75-9. PubMed ID: 4370454
[No Abstract] [Full Text] [Related]
15. Potentiation of pressor response to angiotensin II at the preoptic area in spontaneously hypertensive rat.
Matsuda T; Shibata K; Abe M; Tomonaga M; Furukawa T
Life Sci; 1987 Aug; 41(6):749-54. PubMed ID: 3613838
[TBL] [Abstract][Full Text] [Related]
16. Intracerebroventricularly infused [D-Arg1]angiotensin III, is superior to [D-Asp1]angiotensin II, as a pressor agent in rats.
Wright JW; Roberts KA; Cook VI; Murray CE; Sardinia MF; Harding JW
Brain Res; 1990 Apr; 514(1):5-10. PubMed ID: 2357530
[TBL] [Abstract][Full Text] [Related]
17. In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
Siegl PK; Chang RS; Mantlo NB; Chakravarty PK; Ondeyka DL; Greenlee WJ; Patchett AA; Sweet CS; Lotti VJ
J Pharmacol Exp Ther; 1992 Jul; 262(1):139-44. PubMed ID: 1625193
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the haemodynamic effects of angiotensin II in conscious rats by AT2-receptor antagonists given after the AT1-receptor antagonist, EXP 3174.
Widdop RE; Gardiner SM; Kemp PA; Bennett T
Br J Pharmacol; 1992 Nov; 107(3):873-80. PubMed ID: 1472980
[TBL] [Abstract][Full Text] [Related]
19. Thromboxane mediation of the pressor response to infused angiotensin II.
Wilcox CS; Welch WJ
Am J Hypertens; 1990 Mar; 3(3):242-9. PubMed ID: 2322437
[TBL] [Abstract][Full Text] [Related]
20. Interactions between angiotensin peptides and the sympathetic nervous system mediating intestinal sodium and water absorption in the rat.
Levens NR; Peach MJ; Carey RM
J Clin Invest; 1981 Apr; 67(4):1197-207. PubMed ID: 7204574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
